To hear about similar clinical trials, please enter your email below
Trial Title:
Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic Cancer
NCT ID:
NCT06108531
Condition:
Pancreatic
Study type:
Observational
Overall status:
Enrolling by invitation
Study design:
Time perspective:
Prospective
Summary:
This is an observational study of patients diagnosed with pancreatic cancer by pathology,
with a control group of patients with pathology suggestive of benign pancreatic lesions
and normal subjects, and the diagnostic ability of exosomes to identify patients with
pancreatic cancer was assessed through the detection of exosomes in the peripheral blood.
Criteria for eligibility:
Study pop:
Cases will be patients with newly diagnosed pancreatic cancer. Controls will be selected
from patients with pancreatitis in the same hospital as the cases, matched by sex, race
and age (1:1). A total of 400 patients with gallbladder cancer will be recruited.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
Diagnosis of pancreatic cancer confirmed by imaging (case) Diagnosis of chronic
pancreatitis confirmed by imaging (hospital control)
Exclusion Criteria:
The pathology diagnosis and imaging does not matched Patients with other malignant tumors
Patients with other severe systemic diseases
Gender:
All
Minimum age:
18 Years
Maximum age:
80 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
Xinhua Hospital, Affiliated to Shanghai Jiao Tong University, School of Medicine
Address:
City:
Shanghai
Zip:
20092
Country:
China
Start date:
November 1, 2023
Completion date:
August 1, 2026
Lead sponsor:
Agency:
Shanghai Jiao Tong University School of Medicine
Agency class:
Other
Source:
Shanghai Jiao Tong University School of Medicine
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06108531
